| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.86 | 0.0003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.096 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.006 |